The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography
Open accessAbstract
Equilibrium striatal: cerebellar 11 C‐raclopride (RAC) uptake ratios reflect the density of striatal dopamine D 2 binding sites. Using positron emission tomographic scanning we have measured striatal RAC uptake in 6 untreated patients with Parkinson's disease (PD), 5 chronically treated patients with PD and a fluctuating response to L‐dopa, 10 patients with striatonigral degeneration (SND), and 9 patients with progressive supranuclear palsy (PSP). Regional cerebral blood flow was determined also, with C 15 O 2. Mean strital: cerebellar RAC uptake was not significantly different from normal in untreated patients with PD, though 2 of these 6 patients showed significantly increased putamen tracer binding. Mean caudate and putamen: cerebellar RAC uptake ratios of the group with PD and fluctuating response to L‐dopa were significantly reduced by 30% and 18%, respectively. The patients with SND had lesser, but significant, 10% and 11% decreases in mean caudate and putamen: cerebellar RAC uptake ratios, respectively, whereas patients with PSP showed 24% and 9% reductions in caudate and putamen: cerebellar RAC binding. Striatal and frontal blood flow were significantly reduced in patients with PSP, but not in patients with PD or SND. In conclusion, striatal D 2 binding potential is normal or raised in untreated patients with PD, but reduced in patients with PD and a fluctuating response to L‐dopa. Patients with SND and PSP show a decrease in striatal RAC binding, but to a lesser extent than patients with PD and a fluctuating response to treatment. Failure of patients with SND and PSP to respond well to L‐dopa cannot therefore be due to losss of striatal D 2 sites alone, but must reflect loss of other basal ganglia connections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., & Seitelberger, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,651
STEELE, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,924
Frackowiak, R. S. J., Lenzi, G.-L., Jones, T., & Heather, J. D. (1980) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198012000-00001 · Cited by 1,242
Self-citationQuantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
Farde, L., Hall, H., Ehrin, E., & Sedvall, G. (1986) · Science · doi:10.1126/science.2867601 · Cited by 831
Wong, D. F., Wagner, H. N., Dannals, R. F., Links, J. M., Frost, J. J., Ravert, H. T., Wilson, A. A., Rosenbaum, A. E., Gjedde, A., Douglass, K. H., et al. (1984) · Science · doi:10.1126/science.6334363 · Cited by 697
Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs
Farde, L. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250087012 · Cited by 692
Multiple system atrophy--the nature of the beast.
Quinn, N. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.suppl.78 · Cited by 644
Self-citationSUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASE
Marsden, C. D., & Parkes, J. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91146-1 · Cited by 587
Self-citationFarde, L., Eriksson, L., Blomquist, G., & Halldin, C. (1989) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1989.98 · Cited by 448
Receptor basis for dopaminergic supersensitivity in Parkinson's disease
LEE, T., SEEMAN, P., RAJPUT, A., FARLEY, I. J., & HORNYKIEWICZ, O. (1978) · Nature · doi:10.1038/273059a0 · Cited by 446
Lesser, R. P., Fahn, S., Snider, S. R., Cote, L. J., Isgreen, W. P., & Barrett, R. E. (1979) · Neurology · doi:10.1212/wnl.29.9_part_1.1253 · Cited by 319
Dopamine receptors in human brain: Autoradiographic distribution of D2 sites
Camps, M., Cortés, R., Gueye, B., Probst, A., & Palacios, J. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90179-6 · Cited by 305
Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidol
Fields, J. Z., Reisine, T. D., & Yamamura, H. I. (1977) · Brain Research · doi:10.1016/0006-8993(77)90084-1 · Cited by 296
Physical performance of the latest generation of commercial positron scanner
Spinks, T. J., Jones, T., Gilardi, M. C., & Heather, J. D. (1988) · IEEE Transactions on Nuclear Science · doi:10.1109/23.12819 · Cited by 287
Neurotransmitter receptor alterations in Parkinson's disease
Reisine, T. D., Fields, J. Z., Yamamura, H. I., Bird, E. D., Spokes, E., Schreiner, P. S., & Enna, S. J. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90514-8 · Cited by 252
CILIARY MOVEMENT IN THE RAT CEREBRAL VENTRICLES: CLEARING ACTION AND DIRECTIONS OF CURRENTS*†
CATHCART, R. S., & WORTHINGTON, W. C. (1964) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-196410000-00002 · Cited by 238
Maher, E. R., & Lees, A. J. (1986) · Neurology · doi:10.1212/wnl.36.7.1005 · Cited by 234
Self-citationFAHN, S. (1974) · Neurology · doi:10.1212/wnl.24.5.431 · Cited by 230
Dopaminergic and cholinergic lesions in progressive supranuclear palsy
Ruberg, M., Javoy‐Agid, F., Hirsch, E., Scatton, B., Lheureux, R., Hauw, J., Duyckaerts, C., Gray, F., Morel‐Maroger, A., Rascol, A., et al. (1985) · Annals of Neurology · doi:10.1002/ana.410180503 · Cited by 221
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
Bokobza, B., Ruberg, M., Scatton, B., Javoy-Agid, F., & Agid, Y. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90238-3 · Cited by 210
Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography
Foster, N. L., Gilman, S., Berent, S., Morin, E. M., Brown, M. B., & Koeppe, R. A. (1988) · Annals of Neurology · doi:10.1002/ana.410240308 · Cited by 208
Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders
Brücke, T., Podreka, I., Angelberger, P., Wenger, S., Topitz, A., Küfferle, B., Müller, C., & Deecke, L. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.53 · Cited by 206
Blin, J. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530070035009 · Cited by 203
Kuhl, D. E., Metter, E. J., & Riege, W. H. (1984) · Annals of Neurology · doi:10.1002/ana.410150504 · Cited by 178
Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease
WOLFSON, L. I., Leenders, K. L., Brown, L. L., & Jones, T. (1985) · Neurology · doi:10.1212/wnl.35.10.1399 · Cited by 154
Rinne, U. K., Laihinen, A., Rinne, J. O., Någren, K., Bergman, J., & Ruotsalainen, U. (1990) · Movement Disorders · doi:10.1002/mds.870050114 · Cited by 150
STEELE-RICHARDSON-OLSZEWSKI SYNDROME
Leenders, K. L., Frackowiak, R. S. J., & Lees, A. J. (1988) · Brain · doi:10.1093/brain/111.3.615 · Cited by 136
Self-citationPositron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy
Goffinet, A. M., Voider, A. D., Gillain, C., Rectem, D., Bol, A., Michel, C. J., Cogneau, M., Labar, D., & Laterre, C. (1989) · Annals of Neurology · doi:10.1002/ana.410250205 · Cited by 128
Volder, A. D., Francart, J., Laterre, C., Dooms, G., Bol, A., Michel, C. J., & Goffinet, A. M. (1989) · Annals of Neurology · doi:10.1002/ana.410260210 · Cited by 117
Baron, J., Maziere, B., Loc’h, C., Cambon, H., Sgouropoulos, P., Bonnet, A. M., & Agid, Y. (1986) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1986.26 · Cited by 110
Cortés, R., Camps, M., Gueye, B., Probst, A., & Palacios, J. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)90031-0 · Cited by 109
Hägglund, J. V., Sm, A., Eckernas, S., Hartvig, P., Lundquist, H., Gullberg, P., & Långström, B. (1987) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1987.tb07900.x · Cited by 108
Dopamine receptors in the parkinsonian brain
Rinne, U. K., Lönnberg, P., & Koskinen, V. (1981) · Journal of Neural Transmission · doi:10.1007/bf01664007 · Cited by 104
Bethlem, J., & Jager, W. A. D. H. (1960) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.74 · Cited by 102
Pierot, L., Desnos, C., Blin, J., Raisman‐Vozari, R., Scherman, D., Javoy-Agid, F., Ruberg, M., & Agid, Y. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90106-2 · Cited by 101
Fuxé, K., Agnati, L. F., Köhler, C., Kuonen, D., Ögren, S. O., Andersson, K., & Hökfelt, T. G. M. (1981) · Journal of Neural Transmission · doi:10.1007/bf01664003 · Cited by 88
Chemical lesion and drug induced supersentivity and subsensitivity of caudate dopamine receptors
Mishra, R. K., Wong, Y.-W., Varmuza, S., & Tuff, L. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90150-9 · Cited by 77
The natural history of non-arteritic anterior ischaemic optic neuropathy.
Sawle, G. V., James, C. B., & Russell, R. W. R. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.10.830 · Cited by 73
Self-citationQuik, M., Spokes, G., Mackay, A. V. P., & Bannister, R. (1979) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(79)90021-2 · Cited by 68
Self-citationSalmon, É., Brooks, D. J., Leenders, K. L., Turton, D. R., Hume, S. P., Cremer, J. E., Jones, T., & Frackowiak, R. S. J. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.59 · Cited by 65
Self-citation
Cited by
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
The diagnosis of Parkinson’s disease
Tolosa, E., Wenning, G., & Poewe, W. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70285-4 · Cited by 902
Multiple system atrophy: A review of 203 pathologically proven cases
Wenning, G. K., Tison, F., ben Shlomo, Y., Daniel, S. E., & Quinn, N. P. (1997) · Movement Disorders · doi:10.1002/mds.870120203 · Cited by 803
Self-citationPathophysiology of levodopa-induced dyskinesia: Potential for new therapies
Bezard, E., Brotchie, J. M., & Gross, C. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 503
EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease
Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V., Brooks, D., Burn, D. J., Colosimo, C., Fanciulli, A., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12022 · Cited by 489
Self-citation
Metadata
- Authors
- Brooks, D. J., Ibanez, V., Sawle, G. V., Playford, E. D., Quinn, N., Mathias, C. J., Lees, A. J., Marsden, C. D., Bannister, R., & Frackowiak, R. S. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1992-02
- Volume
- 31
- Issue
- 2
- Pages
- 184-192
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2104004822
- Cited by
- 396
- References
- 43
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.